Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs
Authors:
- 8 September 2021
- journal article
- review article
- Published by Elsevier in Trends in Genetics
- Vol. 37 (12) , 1109-1123
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K99 HL150319, R01 HL126527, R01 HL141371, R01 HL145676)
- Tobacco-Related Disease Research Program (R01 HL123968, R01 HL150693)
This publication has 123 references indexed in Scilit:
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated CardiomyopathyScience Translational Medicine, 2012
- Genetics of Human Cardiovascular DiseaseCell, 2012
- Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndromeNature, 2011
- Genetic Mapping in Human DiseaseScience, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Mutations in NOTCH1 cause aortic valve diseaseNature, 2005
- GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5Nature, 2003
- Beyond Mendel: an evolving view of human genetic disease transmissionNature Reviews Genetics, 2002